How to assess kidney outcomes in obese people with substantial weight loss: the case of GLP1- and dual-receptor agonists.
Nephrol Dial Transplant
; 39(7): 1060-1062, 2024 Jun 28.
Article
in En
| MEDLINE
| ID: mdl-38299776
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Weight Loss
/
Obesity
Limits:
Humans
Language:
En
Journal:
Nephrol Dial Transplant
Journal subject:
NEFROLOGIA
/
TRANSPLANTE
Year:
2024
Document type:
Article
Affiliation country:
Country of publication: